The global d-mannose market is dominated by players such as Now Health Group Inc., Nutraceutical International Corp., E. I. du Pont de Nemours and Company, and Jarrow Formulas Inc. While these players are likely to establish dominant shares in the global d-mannose market in the coming years, the nascent origin of the market has made it highly lucrative for new entrants. Other key players in the global d-mannose market include VWR Corporation, Atrium Innovations Inc., Ferro Pfanstiehl Laboratories, Inc., Hänseler AG, Kyowa Hakko Kirin Co Ltd, and Bio-Tech Pharmacal Inc. Expansion of manufacturing capacity is likely to remain a key growth avenue for players in the global d-mannose market in the coming years, with larger players likely to target smaller players in emerging markets in order to make the most of the burgeoning opportunity in developing regions.
According to Transparency Market Research (TMR), the global d-mannose market is likely to exhibit a CAGR of 3.5% from 2017 to 2025. The global d-mannose market was valued at US$774.5 mn in 2017 and is likely to rise to US$1,016.7 mn by the end of 2025.
By application, dietary supplements dominate the global d-mannose market, with pharmaceuticals and functional food also likely to contribute significantly to the global market’s growth in the coming years. The dietary supplements segment is likely to grow to a revenue valuation of US$440.5 mn by 2025, representing more than 40% of the global d-mannose market. Functional food, on the other hand, is likely to exhibit the highest CAGR, with the segment expected to grow at 4% over the 2017-2025 forecast period.
Increasing Prevalence of UTIs in Developed Countries Drives D-Mannose Market
One of the prime drivers for the global d-mannose market is the growing awareness of the utility of d-mannose, which is a form of glucose but with several differing chemical characteristics, in preventing urinary tract infections (UTIs). Unlike glucose, mannose has the property of clinging to the walls of the urinary tract, making it harder for pathogens to attach themselves to the surface. This makes it the perfect preventive tool for UTIs, as UTIs are usually treated with antibiotics, several of which are facing consistent resistance.
Get PDF Report Brochure for more Info@http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14363
The global d-mannose market has also gained a significant part of its demand from products designed for diabetic or other calorie-conscious demographics, as mannose is not metabolized like glucose in the body and thus doesn’t contribute to the blood sugar levels. Most of d-mannose is absorbed in the preliminary parts of the digestive tract, making it safe for diabetic individuals. The growing scope of specialist diets due to the rapid development of long-distance shipping facilities is thus likely to help the global d-mannose market.
North America has emerged as the leading contributor to the global d-mannose market. The growing prevalence of urinary tract infections in North America has fueled the development of alternative treatments such as d-mannose. The growing availability of healthcare information to the masses has also helped the growth of the d-mannose market as an alternative or supplementary to conventional UTI treatments. The high prevalence of diabetes in regions such as the U.S. is also likely to remain a key driver for the d-mannose market in North America in the coming years. The growing prevalence of diabetes in Southeast Asia is also likely to be vital for the global d-mannose market.